The pathology of human diabetic neuropathy

Diabetes

Volumn 46, Issue SUPPL. 2, 1997, Pages

  Malik, R A ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CELL HYPERPLASIA; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC NEUROPATHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MYELINATED NERVE; NERVE REGENERATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0030964550     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.2.s50     Document Type: Conference Paper

References (37)

1. Boulton AJM: Foot problems in patients with diabetes mellitus. In Textbook of Diabetes. Vol. 2. Pickup J, Williams G, Eds. Oxford, Blackwell Science, 1997, p. 58.1-58.20
2. Ward JD, Tesfaye S: Pathogenesis of human diabetic neuropathy. In Textbook of Diabetes. Vol. 2. Pickup J, Williams G, Eds. Oxford, Blackwell Science, 1997, p. 49.1-49.19
3. Greene DA, Lattimer SA, Sima AAF: Sorbitol, phosphinositol and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316:599-606, 1987
4. Dyck PJ, Sherman WR, Hallcher LM, Service FJ, O'Brien PC, Grina LA, Palumbo PH, Swanson CJ: Human diabetic endoneurial sorbitol, fructose and myoinositol related to sural nerve morphometry. Ann Neurol 8:590-596, 1980
5. Dyck PJ, Zimmerman BR, Vilen TH, Minnerath SR, Karnes JL, Yao JK, Poduslo JF: Nerve glucose, fructose, sorbitol, myoinositol, and fibre degeneration and regeneration in diabetic neuropathy. N Engl J Med 319:542-548, 1988
6. Nicolucci A, Carinci F, Cavaliere D, Scorpiglione N, Belfiglio M, Labbrozzi D, Mari E, Massi Bendetti M, Tognoni G: A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. Diabetic Med 13:1017-1026, 1996
7. Tuck RR, Schmelzer JD, Low PA: Endoneurial blood flow and endoneurial oxygen tension in the sciatic nerve of rats with experimental diabetic neuropathy. Brain 107:935-950, 1984
8. Tesfaye S, Malik RA, Ward JD: Vascular factors in diabetic neuropathy. Diabetologia 37:847-854, 1994
9. Newrick PJ, Wilson AJ, Jakubowski J, Boulton AJM, Ward JD: Sural nerve oxygen tension in diabetes. Br Med J 293:1053-1054, 1986
10. Malik RA, Masson EA, Sharma AK, Lye RH, Ah-See AK, Compton AM, Tomlinson DR, Boulton AJM: Hypoxic neuropathy relevance to human diabetic neuropathy. Diabetologia 33:311-318, 1990
11. Ford I, Malik RA, Newrick PG, Preston EF, Ward JD, Greaves M: Relationship between haemostatic factors and capillary morphology in human diabetic neuropathy. Thromb Haemost 68:628-633, 1992
12. Giannini C, Dyck PJ: Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity. Ann Neurol 37:498-504, 1995
13. Malik RA, Veves A, Masson EA, Sharma AK, Ah-See AK, Schady W, Lye RH, Boulton AJM: Endoneurial capillary abnormalities in mild human diabetic neuropathy. J Neurol Neurosurg Psychiatry 55:557-561, 1992
14. Timperley WR, Boulton AJM, Davies-Jones GAB, Jarratt JA, Ward JD: Small vessel disease in progressive diabetic neuropathy. J Clin Pathol 38:1030-1038, 1985
15. Powell HC, Rosoff J, Myers RR: Microangiopathy in human diabetic neuropathy. Acta Neuropathol 68:295-305, 1985
16. Dyck PJ, Hansen S, Karnes J, O'Brien P, Yasuda H, Windebank A: Capillary number and percentage closed in human diabetic sural nerve. Proc Natl Acad Sci USA 82:2513-2517, 1985
17. Yasuda H, Dyck PJ: Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology 37:20-28, 1987
18. Bradley J, Thomas PK, King RHM, Llewellyn JG, Muddle JR, Watkins PJ: Morphometry of endoneurial capillaries in diabetic sensory and autonomic neuropathy. Diabetologia 33:611-618, 1990
19. Britland ST, Young RJ, Sharma AK, Clarke BF: Relationship of endoneurial capillary abnormalities to type and severity of diabetic polyneuropathy. Diabetes 39:909-913, 1990
20. Sima AAF, Nathaniel V, Prashar A, Bril V, Greene DA: Endoneurial microvessels in human diabetic neuropathy. Endothelial cell dysjunction and lack of treatment effect by aldose reductase inhibitor. Diabetes 40:1090-1099, 1991
21. Malik RA, Newrick PG, Sharma AK, Jennings A, Ah-See AK, Mayhew TM, Jakubowski J, Boulton AJM, Ward JD: Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 32:92-102, 1989
22. Giannini C, Dyck PJ: Ultrastructural morphometric abnormalities of sural nerve endoneurial microvessels in diabetes mellitus. Ann Neurol 36:408-415, 1994
23. Malik RA, Tesfaye S, Thompson SD, Veves A, Sharma AK, Boulton AJM, Ward JD: Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia 36:454-459, 1993
24. Korthals JK, Geiron MA, Dyck PJ: Intima of epineurial arterioles is increased in diabetic polyneuropathy. Neurology 38:1682-1586, 1988
25. Malik RA, Tesfaye S, Thompson SD, Veves A, Hunter A, Sharma AK, Ward JD, Boulton AJM: Transperineurial capillary abnormalities in the sural nerve of patients with diabetic neuropathy. Microvasc Res 48:236-245, 1994
26. Sima AAF, Nathaniel V, Bril V, McEwan TAJ, Greene DA: Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy. J Clin Invest 81:349-364, 1988
27. Dyck PJ, Giannini C: Pathologic alterations in the diabetic neuropathies of humans: a review. J Neuropathol Exp Neurol 55:1181-1193, 1996
28. Dyck PJ: Detection, characterisation and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 11:21-32, 1988
29. Ochoa J: Recognition of unmyelinated fiber disease: morphologic criteria. Muscle Nerve 1:375-387, 1978
30. Britland ST, Young RJ, Sharma AK, Clarke BF: Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration. Diabetes 39:898-908, 1990
31. Fagerberg SE: Diabetic neuropathy: a clinical and histological study on the significance of vascular affections. Acta Med Scand 164:100-109, 1959
32. Ziegler D, Mayer P, Gries F: Evaluation of thermal, pain, and vibration sensation thresholds in newly diagnosed type 1 diabetic patients. J Neurol Neurosurg Psychiatry 51:1420-1424, 1988
33. Llewellyn JG, Gilbey SG, Thomas PK, King RHM, Muddle JR, Watkins PJ: Sural nerve morphometry in diabetic autonomic end painful sensory neuropathy. Brain 114:867-892, 1991
34. Britland ST, Young RJ, Sharma AK, Clarke BF: Association of painful and painless diabetic polyneuropathy with different patterns of nerve fibre degeneration and regeneration. Diabetes 39:898-908, 1990
35. Anand P, Terenghi G, Warner G, Kopelman P, Williams-Chestnut RE, Sinicropi DV: The role of endogenous nerve growth factor in diabetic neuropathy. Nature Med 2:703-707, 1996
36. Thomas PK: Growth factors and diabetic neuropathy. Diabetic Med 11:732-739, 1994
37. Dyck PJ: Nerve growth factor and diabetic neuropathy. Lancet 348:1044-1045, 1996